tradingkey.logo
tradingkey.logo
Search

IDEAYA Biosciences Inc

IDYA
Add to Watchlist
38.340USD
-0.270-0.70%
Market hours 09/18, 14:05ET
3.70BMarket Cap
LossP/E TTM

IDEAYA Biosciences Inc (IDYA) Revenue Performance

Updated: Dec 31, 2025

Last year, IDEAYA Biosciences Inc generated 7.00M USD for its biggest-performing segment, WRN. The United States made the largest contribution, accounting for 218.71M USD last year. For the latest quarter, IDEAYA Biosciences Inc reported the revenue of 7.00M USD for the period ending 2024-12-31, which came from the top-performing segment, WRN. United States contributed the highest revenue, at 0.00 USD.

By Business

Annual
Annual
Quarterly
WRN
MAT2A
Pol Theta
FY2024
FY2023
FY2022
FY2021
WRN
7.00M(100.00%)
16.66M(71.25%)
7.28M(14.30%)
7.82M(27.98%)
MAT2A
--(--)
3.72M(15.92%)
29.76M(58.42%)
7.23M(25.88%)
Pol Theta
--(--)
3.00M(12.84%)
13.89M(27.28%)
12.89M(46.15%)

By Region

Annual
Annual
Quarterly
United States
FY2025
FY2024
United States
218.71M(100.00%)
7.00M(100.00%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.